| Optimal conditions for hybridization with oligonucleotides: a study with myc-oncogene DNA probes. | None |
| Serum levels of c-myc and c-ras oncogene products in normal subjects and in patients with neoplastic and non neoplastic conditions. | None |
| A novel tumour marker related to the c-myc oncogene product. | None |
| Proteins encoded by the c-myc oncogene: analysis of c-myc protein degradation. | None |
| An atypical t(12;15) translocation of chromosomes found in murine plasmacytomas and activation of the c-myc oncogene. | None |
| Phorbol ester-induced terminal differentiation is inhibited in human U-937 monoblastic cells expressing a v-myc oncogene. | None |
| Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms. | None |
| The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. | None |
| Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens. | None |
| A translocated human c-myc oncogene is altered in a conserved coding sequence. | None |
| Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. | None |
| Expression of the c-myc proto-oncogene during development of Xenopus laevis. | None |
| Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in human placenta: implication for trophoblast proliferation and differentiation. | None |
| Expression of c-myc oncogene in coeliac disease. | None |
| Regulation of expression of the c-myc proto-oncogene. | None |
| Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression. | None |
| Rodent fibroblast tumours expressing human myc and ras genes: growth, metastasis and endogenous oncogene expression. | None |
| Expression of c-Myc, c-Myb, c-Erb-B and c-H-Ras oncogene mRNAs in fibroblasts cultured from psoriatic patients. | None |
| Characterization of a MH2 mutant lacking the v-myc oncogene. | None |
| Activation of the c-myc oncogene. | None |